29-Oct-2026 08:30:05

UBS ON HINDUSTAN UNILEVER ; BUY | TP ₹2,700

• Q2 Revenue: UP 14.8% YoY. • Volume Growth: UP 7%, beating estimates. • Home Care: Sales UP 22%, reflecting strong segment performance. • Beauty & Wellbeing: Sales UP 16%. • Q2 EBITDA: UP 8% YoY. • Net Profit: UP 8.7% YoY. • Outlook: UBS sees strong overall performance, supported by healthy volume growth and broad-based segment expansion. • Impact: Positive 🟢

HINDUSTAN UNILEVER LTD.

← Back to feed